Ö. DİKMETAŞ Et Al. , "The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab," MOLECULAR VISION , vol.19, pp.2571-2578, 2013
DİKMETAŞ, Ö. Et Al. 2013. The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab. MOLECULAR VISION , vol.19 , 2571-2578.
DİKMETAŞ, Ö., KADAYIFÇILAR, S., & Eldem, B., (2013). The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab. MOLECULAR VISION , vol.19, 2571-2578.
DİKMETAŞ, ÖZLEM, SİBEL KADAYIFÇILAR, And Bora Eldem. "The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab," MOLECULAR VISION , vol.19, 2571-2578, 2013
DİKMETAŞ, ÖZLEM Et Al. "The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab." MOLECULAR VISION , vol.19, pp.2571-2578, 2013
DİKMETAŞ, Ö. KADAYIFÇILAR, S. And Eldem, B. (2013) . "The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab." MOLECULAR VISION , vol.19, pp.2571-2578.
@article{article, author={ÖZLEM DİKMETAŞ Et Al. }, title={The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab}, journal={MOLECULAR VISION}, year=2013, pages={2571-2578} }